| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10792-017-0655-7 |
| P698 | PubMed publication ID | 28741232 |
| P50 | author | Mohamed E Shaker | Q83400694 |
| Dalia A. Sabry | Q96096442 | ||
| P2093 | author name string | Maha E Houssen | |
| Amr El-Kannishy | |||
| Mona Abo Bakr El-Hussiny | |||
| Rasha El Mahdy | |||
| P2860 | cites work | Cutting Edge: Role of IL-27/WSX-1 Signaling for Induction of T-Bet Through Activation of STAT1 During Initial Th1 Commitment | Q24301442 |
| Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen | Q24561512 | ||
| Interleukin-27: balancing protective and pathological immunity | Q26830400 | ||
| Vitreous mediators in retinal hypoxic diseases | Q27028225 | ||
| Biochemistry and molecular cell biology of diabetic complications | Q28131781 | ||
| IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells | Q28214882 | ||
| IL-12 concentrations in the aqueous humor and serum of diabetic retinopathy patients | Q34121400 | ||
| Interleukin-27-mediated suppression of human Th17 cells is associated with activation of STAT1 and suppressor of cytokine signaling protein 1. | Q34875271 | ||
| Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation | Q36732543 | ||
| Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1. | Q37202267 | ||
| Suppressors of cytokine-signaling proteins induce insulin resistance in the retina and promote survival of retinal cells | Q37374334 | ||
| Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications | Q37512877 | ||
| Interleukin 27: a double-edged sword for offense and defense | Q37607910 | ||
| Leukocyte adhesion molecules in diabetic retinopathy | Q39111812 | ||
| Retinal cells suppress intraocular inflammation (uveitis) through production of interleukin-27 and interleukin-10. | Q39597798 | ||
| IL-27 limits IL-2 production during Th1 differentiation. | Q42676181 | ||
| Is diabetic retinopathy an inflammatory disease? | Q43009558 | ||
| Quantitative determination of serum triglycerides by the use of enzymes | Q43418524 | ||
| Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study | Q44495277 | ||
| IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells | Q46043684 | ||
| Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. | Q51679983 | ||
| A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. | Q55045567 | ||
| The 4-hydroxybenzoate/4-aminophenazone chromogenic system used in the enzymic determination of serum cholesterol | Q67415772 | ||
| Hemoglobin components in patients with diabetes mellitus | Q71748906 | ||
| Increased interleukin-12 plasma concentrations in both, insulin-dependent and non-insulin-dependent diabetes mellitus | Q74485864 | ||
| IL-27 induces Th1 differentiation via p38 MAPK/T-bet- and intercellular adhesion molecule-1/LFA-1/ERK1/2-dependent pathways | Q79370177 | ||
| Interleukin-12 and tumour necrosis factor-alpha equilibrium is a prerequisite for clinical course free from late complications in children with type 1 diabetes mellitus | Q80506814 | ||
| Diabetic retinopathy | Q84482290 | ||
| P433 | issue | 5 | |
| P921 | main subject | interleukins | Q194908 |
| diabetic retinopathy | Q631361 | ||
| P304 | page(s) | 1817-1823 | |
| P577 | publication date | 2017-07-24 | |
| P1433 | published in | International Ophthalmology | Q15763839 |
| P1476 | title | Serum and aqueous humor concentrations of interleukin-27 in diabetic retinopathy patients. | |
| P478 | volume | 38 |
Search more.